Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of <i>EGFR</i> / <i>KRA</i> S and Presence of <i>PIK3CA</i> / <i>AKT1</i> MutationsNatasha Rekhtman, Marc Ladanyi, Paul K. Paik et al.|Clinical Cancer Research|2012Cited by 365
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung CancerYasushi Yatabe, André L. Moreira|Journal of Thoracic Oncology|2018Cited by 350
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Hongbin Ji, Yueqing Chen et al.|Cancer Cell|2024Cited by 115
Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patientsHua‐Jun Wu, Franziska Michor, Zoltan Maliga et al.|Cell Genomics|2022Cited by 51
Deep learning integrates histopathology and proteogenomics at a pan-cancer levelJoshua M. Wang, Nathan Edwards, Runyu Hong et al.|Cell Reports Medicine|2023Cited by 33